Advancing Lung Cancer Research
Last year saw significant progress against lung cancer, with seven new therapeutics, including two immunotherapeutics, approved by the U.S....
Tag: Lung cancer
Last year saw significant progress against lung cancer, with seven new therapeutics, including two immunotherapeutics, approved by the U.S....
It’s that time of year when we reflect on the progress we made over the past 12 months –...
The rapid fire of U.S. Food and Drug Administration (FDA) approvals of new anticancer therapeutics continued last week when...
As lung cancer awareness month drew to a close, the U.S. Food and Drug Administration (FDA) added another therapeutic...
Last week, the U.S. Food and Drug Administration (FDA) provided some good news for the lung cancer community during...
Late last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the...
On the heels of the U.S. Food and Drug Administration’s approval of a combination of immune checkpoint inhibitors for...
Guest Post by Kelvin Lee, MD Roswell Park Cancer Institute
Guest Post by Dario C. Altieri, MD The Wistar Institute
The field of cancer immunotherapy broke new ground last week when the U.S. Food and Drug Administration (FDA) announced...